{
    "id": "fd1a8548c9",
    "abstract": [],
    "body_text": [
        {
            "text": "Acute myeloid leukemia (AML) is one of the most wellstudied diseases in the genomic research area [1,2]. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 98,
                    "end": 101,
                    "type": "bibr",
                    "ref_id": "b0",
                    "text": "[1,"
                },
                {
                    "start": 101,
                    "end": 103,
                    "type": "bibr",
                    "ref_id": "b1",
                    "text": "2]"
                }
            ]
        },
        {
            "text": "AML occurs usually in middle-aged people and is diagnosed by increasing leukemic myeloblasts in blood over 30% [3]. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 111,
                    "end": 114,
                    "type": "bibr",
                    "ref_id": "b2",
                    "text": "[3]"
                }
            ]
        },
        {
            "text": "AML is a genetically heterogeneous disease, since 1/3 of AML patients have chromosomal rearrangements, like t(8;21) and t (15;17), but other AML patients have normal karyotypes [4]. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 122,
                    "end": 129,
                    "type": "bibr",
                    "text": "(15;17)"
                },
                {
                    "start": 177,
                    "end": 180,
                    "type": "bibr",
                    "ref_id": "b3",
                    "text": "[4]"
                }
            ]
        },
        {
            "text": "With recent advances of high-throughput genomic technology, a favorable prognosis has been observed with some genetic changes in cytogenetically normal AML [5]. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 156,
                    "end": 159,
                    "type": "bibr",
                    "ref_id": "b4",
                    "text": "[5]"
                }
            ]
        },
        {
            "text": "These results were reflected by the World Health Organization (WHO) diagnostic criteria; the NMP1 and CEBPA mutations were included in the 2008 revision of these criteria [6]. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 171,
                    "end": 174,
                    "type": "bibr",
                    "ref_id": "b5",
                    "text": "[6]"
                }
            ]
        },
        {
            "text": "The molecular change of AML is considered to be the accumulation of somatic mutations in hematopoietic progenitor cells [7]. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 120,
                    "end": 123,
                    "type": "bibr",
                    "ref_id": "b6",
                    "text": "[7]"
                }
            ]
        },
        {
            "text": "Next-generation sequencing technology gave us new insights into the clonal heterogeneity of leukemic mutations so that we can make an explanation why some of these mutations are highly re-producible but others are very rare [8]. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 224,
                    "end": 227,
                    "type": "bibr",
                    "ref_id": "b7",
                    "text": "[8]"
                }
            ]
        },
        {
            "text": "Still, in 30% of cytogenetically normal AML, the genetic causality origin or strongly associated genetic changes have not yet been discovered [9,10].",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 142,
                    "end": 145,
                    "type": "bibr",
                    "ref_id": "b8",
                    "text": "[9,"
                },
                {
                    "start": 145,
                    "end": 148,
                    "type": "bibr",
                    "ref_id": "b9",
                    "text": "10]"
                }
            ]
        },
        {
            "text": "With advances of high-throughput technology, discovery of disease-associated genes is growing [11]. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 94,
                    "end": 98,
                    "type": "bibr",
                    "ref_id": "b10",
                    "text": "[11]"
                }
            ]
        },
        {
            "text": "As a consequence, the genetic knowledge databases are growing rapidly. ",
            "section": "Introduction"
        },
        {
            "text": "Accordingly, the annotation of candidate causal genes in genetic studies is a very challenging process for researchers. ",
            "section": "Introduction"
        },
        {
            "text": "We propose a workflow of the detection of somatic mutation candidates in 10 normal matched AML samples and introduce concept lattice analysis for clustering the samples that have highly mutated genes in common.",
            "section": "Introduction"
        },
        {
            "text": "We received the fastq files of whole-exome sequencing results of tumor and matched normal sample data of 10 AML patients from the Korea Genome Organization in December 2012. ",
            "section": "Primacy sequence analysis"
        },
        {
            "text": "There were no patient-related medical or characteristic data. ",
            "section": "Primacy sequence analysis"
        },
        {
            "text": "We aligned the sequencing reads to the human reference genome (hg 19, GRCh37) from USCC by BWA 0.6.2 [12] (Figs. 1 and 2). ",
            "section": "Primacy sequence analysis",
            "ref_spans": [
                {
                    "start": 101,
                    "end": 105,
                    "type": "bibr",
                    "text": "[12]"
                },
                {
                    "start": 106,
                    "end": 121,
                    "type": "figure",
                    "text": "(Figs. 1 and 2)"
                }
            ],
            "entity_spans": [
                {
                    "start": 91,
                    "end": 94,
                    "type": "software",
                    "rawForm": "BWA",
                    "resp": "#annotator5",
                    "used": true,
                    "id": "fd1a8548c9-software-11",
                    "cert": "1.0"
                },
                {
                    "start": 95,
                    "end": 100,
                    "type": "version",
                    "rawForm": "0.6.2",
                    "resp": "#annotator5",
                    "id": "#fd1a8548c9-software-11"
                },
                {
                    "type": "software",
                    "start": 91,
                    "end": 94,
                    "rawForm": "BWA",
                    "resp": "whitelist",
                    "id": "fd1a8548c9-software-simple-w0"
                }
            ]
        },
        {
            "text": "To filter the known single nucleotide polymorphisms (SNPs), we used dbSNP bulid 137. ",
            "section": "Primacy sequence analysis"
        },
        {
            "text": "We removed PCR duplicates and filtering low-quality SNPs bySamtools 0.1.18 [13], Picard 1.68 [14], and GATK 2.3.4 [15]. ",
            "section": "Primacy sequence analysis",
            "ref_spans": [
                {
                    "start": 75,
                    "end": 79,
                    "type": "bibr",
                    "text": "[13]"
                },
                {
                    "start": 93,
                    "end": 97,
                    "type": "bibr",
                    "text": "[14]"
                },
                {
                    "start": 114,
                    "end": 118,
                    "type": "bibr",
                    "text": "[15]"
                }
            ],
            "entity_spans": [
                {
                    "start": 59,
                    "end": 67,
                    "type": "software",
                    "rawForm": "Samtools",
                    "resp": "#annotator8",
                    "used": true,
                    "id": "fd1a8548c9-software-8",
                    "cert": "1.0"
                },
                {
                    "start": 68,
                    "end": 74,
                    "type": "version",
                    "rawForm": "0.1.18",
                    "resp": "#annotator8",
                    "id": "#fd1a8548c9-software-8"
                },
                {
                    "start": 81,
                    "end": 87,
                    "type": "software",
                    "rawForm": "Picard",
                    "resp": "#annotator8",
                    "used": true,
                    "id": "fd1a8548c9-software-9",
                    "cert": "1.0"
                },
                {
                    "start": 88,
                    "end": 92,
                    "type": "version",
                    "rawForm": "1.68",
                    "resp": "#annotator8",
                    "id": "#fd1a8548c9-software-9"
                },
                {
                    "start": 103,
                    "end": 107,
                    "type": "software",
                    "rawForm": "GATK",
                    "resp": "#annotator8",
                    "used": true,
                    "id": "fd1a8548c9-software-10",
                    "cert": "1.0"
                },
                {
                    "start": 108,
                    "end": 113,
                    "type": "version",
                    "rawForm": "2.3.4",
                    "resp": "#annotator8",
                    "id": "#fd1a8548c9-software-10"
                },
                {
                    "type": "software",
                    "start": 81,
                    "end": 87,
                    "rawForm": "Picard",
                    "resp": "whitelist",
                    "id": "fd1a8548c9-software-simple-w1"
                },
                {
                    "type": "software",
                    "start": 103,
                    "end": 107,
                    "rawForm": "GATK",
                    "resp": "whitelist",
                    "id": "fd1a8548c9-software-simple-w2"
                }
            ]
        },
        {
            "text": "After the filtering process, the SAM file was converted to VCF file by VCF Tools 0.1.10 [16]. ",
            "section": "Primacy sequence analysis",
            "ref_spans": [
                {
                    "start": 88,
                    "end": 92,
                    "type": "bibr",
                    "text": "[16]"
                }
            ],
            "entity_spans": [
                {
                    "start": 71,
                    "end": 80,
                    "type": "software",
                    "rawForm": "VCF Tools",
                    "resp": "#annotator5",
                    "used": true,
                    "id": "fd1a8548c9-software-15",
                    "cert": "1.0"
                },
                {
                    "start": 81,
                    "end": 87,
                    "type": "version",
                    "rawForm": "0.1.10",
                    "resp": "#annotator5",
                    "id": "#fd1a8548c9-software-15"
                },
                {
                    "type": "software",
                    "start": 33,
                    "end": 36,
                    "rawForm": "SAM",
                    "resp": "whitelist",
                    "id": "fd1a8548c9-software-simple-w3"
                }
            ]
        },
        {
            "text": "For detecting somatic mutation candidates, we obtained the difference in VCF files between tumor and normal samples. ",
            "section": "Primacy sequence analysis"
        },
        {
            "text": "For annotation of these somatic mutation candidates, we used the ANNOVAR tool [17].",
            "section": "Primacy sequence analysis",
            "ref_spans": [
                {
                    "start": 78,
                    "end": 82,
                    "type": "bibr",
                    "text": "[17]"
                }
            ],
            "entity_spans": [
                {
                    "start": 65,
                    "end": 72,
                    "type": "software",
                    "rawForm": "ANNOVAR",
                    "resp": "#curator",
                    "id": "fd1a8548c9-software-simple-10"
                },
                {
                    "type": "software",
                    "start": 65,
                    "end": 72,
                    "rawForm": "ANNOVAR",
                    "resp": "whitelist",
                    "id": "fd1a8548c9-software-simple-w4"
                }
            ]
        },
        {
            "text": "We used formal concept analysis (FCA) for the construction of hierarchical relationships among samples sharing highly mutated genes [18]. ",
            "section": "Formal concept analysis",
            "ref_spans": [
                {
                    "start": 132,
                    "end": 136,
                    "type": "bibr",
                    "ref_id": "b17",
                    "text": "[18]"
                }
            ]
        },
        {
            "text": "FCA is a useful method in conceptual clustering of objects, attributes, and their binary relationship. ",
            "section": "Formal concept analysis"
        },
        {
            "text": "In FCA, the sets of formal objects and formal attributes together with their relation to each other form a \"formal context,\" which can be represented by a crosstable. ",
            "section": "Formal concept analysis"
        },
        {
            "text": "In our case, the objects are 10 AML samples, and the attributes are 45 highly mutated genes. ",
            "section": "Formal concept analysis"
        },
        {
            "text": "We defined the formal context as K = (G, M, I), where G is a set of objects (i.e., samples), M is a set of attributes (i.e., mutated genes), and I \u2286 G \u00d7 M is the incidence relations where (g, m) \u2286 I if object g has attribute m. ",
            "section": "Formal concept analysis"
        },
        {
            "text": "For A \u2286 G and B \u2286 M, we define the operators A' = {m \u2208 M|gIm for all g \u2208 A} (i.e., the set of attributes common to the objects in A) and B' = {g \u2208 G|gIm for all m \u2208 B} (i.e., the set of objects common to the attributes in B). ",
            "section": "Formal concept analysis"
        },
        {
            "text": "A pair of (A, B) is a formal concept of k(G, M, I) if and only if A \u2286 G, B \u2286 M, A' = B, and A = B'. ",
            "section": "Formal concept analysis"
        },
        {
            "text": "A is called the extent and B is the intent of the concept (A, B). ",
            "section": "Formal concept analysis"
        },
        {
            "text": "The extent consists of all objects belonging to the concept while the intent contains all attributes shared by the objects. ",
            "section": "Formal concept analysis"
        },
        {
            "text": "The concept of a given context is naturally ordered by the subconcept-superconcept relation, defined by (A1, B1) \u2264 (A2, B2):",
            "section": "Formal concept analysis"
        },
        {
            "text": "The ordered set of all concepts of the context (G, M, I) is denoted by C(G, M, I) and is called the concept lattice of (G, M, I). ",
            "section": "Formal concept analysis"
        },
        {
            "text": "We represent the structure of this concept lattice with a Hasse diagram, in which nodes are the concepts and the edges correspond to the neighborhood relationship among the concepts. ",
            "section": "Formal concept analysis"
        },
        {
            "text": "All concepts above an object label (below the attribute label) include that object (attribute). ",
            "section": "Formal concept analysis"
        },
        {
            "text": "The top element of a lattice is a unit concept, representing a concept that contains all objects. ",
            "section": "Formal concept analysis"
        },
        {
            "text": "The bottom element is a zero concept having no object.",
            "section": "Formal concept analysis"
        },
        {
            "text": "We have identified 12,908 somatic mutation candidates in 10 AML sequenced exomes, including 1,281 point mutations, 625 insertion/deletions (Indels) (  (Fig. 4). ",
            "section": "Overview of mutations",
            "ref_spans": [
                {
                    "start": 151,
                    "end": 159,
                    "type": "figure",
                    "ref_id": "fig_2",
                    "text": "(Fig. 4)"
                }
            ]
        },
        {
            "text": "For each patient, the average nonsynonymous mutation count was 429.7 (SD, 97.16). ",
            "section": "Overview of mutations"
        },
        {
            "text": "About 342 to 665 genes have nonsynonymous somatic mutation candidates at least once in each AML sample (Table  2). ",
            "section": "Overview of mutations",
            "ref_spans": [
                {
                    "start": 103,
                    "end": 112,
                    "type": "table",
                    "ref_id": "tab_1",
                    "text": "(Table  2"
                }
            ]
        },
        {
            "text": "Recurrent mutated genes were observed in all samples.",
            "section": "Overview of mutations"
        },
        {
            "text": "The most frequently mutated genes across all samples were USP9Y and MUC5B; these genes were mutated in 5 samples. ",
            "section": "Mutation analysis"
        },
        {
            "text": "These genes were also highly mutated in each sample; for USP9Y genes, it had 6 nonsynonymous mutations in sample 3. ",
            "section": "Mutation analysis"
        },
        {
            "text": "We have selected 45 highly mutated genes (1.5%) from 2981 mutated genes. ",
            "section": "Mutation analysis"
        },
        {
            "text": "We defined highly mutated genes as genes having 3 or more nonsynonymous mutations in each sample (Table 3). ",
            "section": "Mutation analysis",
            "ref_spans": [
                {
                    "start": 97,
                    "end": 105,
                    "type": "table",
                    "text": "(Table 3"
                }
            ]
        },
        {
            "text": "In a comparison of mutations with the COSMIC database [19], among 45 highly mutated genes, 21 genes matched to hematopoietic and lymphoid tissue malignancy terms, and 21 genes matched to other cancer types. ",
            "section": "Mutation analysis",
            "ref_spans": [
                {
                    "start": 54,
                    "end": 58,
                    "type": "bibr",
                    "text": "[19]"
                }
            ],
            "entity_spans": [
                {
                    "type": "software",
                    "start": 38,
                    "end": 44,
                    "rawForm": "COSMIC",
                    "resp": "whitelist",
                    "id": "fd1a8548c9-software-simple-w5"
                }
            ]
        },
        {
            "text": "In 3 genes, there was no matched term in COSMIC (Table 4).",
            "section": "Mutation analysis",
            "ref_spans": [
                {
                    "start": 48,
                    "end": 57,
                    "type": "table",
                    "text": "(Table 4)"
                }
            ],
            "entity_spans": [
                {
                    "type": "software",
                    "start": 41,
                    "end": 47,
                    "rawForm": "COSMIC",
                    "resp": "whitelist",
                    "id": "fd1a8548c9-software-simple-w6"
                }
            ]
        },
        {
            "text": "We used the concept lattice to construct the hierarchical relationship between the samples that had 45 highly mutated genes. ",
            "section": "Mutation analysis"
        },
        {
            "text": "Concept Biolattice analysis is a mathematical framework based on concept lattice analysis for better biological interpretation of genomic data. ",
            "section": "Mutation analysis"
        },
        {
            "text": "The top element of a lattice is a unit concept, representing a concept that contains all objects. ",
            "section": "Mutation analysis"
        },
        {
            "text": "The bottom element is a zero concept having no object [20,21]. ",
            "section": "Mutation analysis",
            "ref_spans": [
                {
                    "start": 54,
                    "end": 58,
                    "type": "bibr",
                    "ref_id": "b19",
                    "text": "[20,"
                },
                {
                    "start": 58,
                    "end": 61,
                    "type": "bibr",
                    "ref_id": "b20",
                    "text": "21]"
                }
            ]
        },
        {
            "text": "For comparing with the Concept lattice (Fig. 5), we also performed hierarchical clustering analysis by Ward method. ",
            "section": "Mutation analysis",
            "ref_spans": [
                {
                    "start": 39,
                    "end": 47,
                    "type": "figure",
                    "ref_id": "fig_3",
                    "text": "(Fig. 5)"
                }
            ]
        },
        {
            "text": "In hierarchical clustering, cluster 1 has 5 samples (nos. 1, 2, 5, 9, and 10), cluster 2 has 2 samples (nos. 4 and 7), and others have 1 sample each (Fig. 6). ",
            "section": "Mutation analysis",
            "ref_spans": [
                {
                    "start": 149,
                    "end": 157,
                    "type": "figure",
                    "text": "(Fig. 6)"
                }
            ]
        },
        {
            "text": "We divided the samples into 4 subgroups by interpretation of the concept lattice result (Fig.  7). ",
            "section": "Mutation analysis",
            "ref_spans": [
                {
                    "start": 88,
                    "end": 97,
                    "type": "figure",
                    "ref_id": "fig_4",
                    "text": "(Fig.  7)"
                }
            ]
        },
        {
            "text": "Lattice subgroup 1 shared SYNE1 gene mutation, and samples 3, 4, and 7 were included in this subgroup. ",
            "section": "Mutation analysis"
        },
        {
            "text": "Subgroup 2 was comprised of 5 samples (nos. 1, 2, 5, 6, and 9) that had MUC5 gene mutations in common. ",
            "section": "Mutation analysis"
        },
        {
            "text": "Samples 10 and 8 could be isolated by the uniqueness of their mutated Genes mutated in 3 samples; c Genes mutated in 2 samples. ",
            "section": "Mutation analysis"
        },
        {
            "text": "Table 3. ",
            "section": "Mutation analysis",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 7,
                    "type": "table",
                    "text": "Table 3"
                }
            ]
        },
        {
            "text": "List of 3 more mutated genes in 10 AML samples  ",
            "section": "Mutation analysis"
        },
        {
            "text": "Gene symbol ABCA7 BRD2 KANSL1 ANKRD18A  C6orf10  FOXD4L6  CDH23  CDSN  HELZ2  CYFIP1  DMBT1  DNAH17  GRIK1  DNAH8  KIF16B  FAM195A  KIFC2  GPR98  MUC5B  ITGAX  MUC6  KIAA1199  MYH10  LAMC3  OR6V1  MLL3  PITRM1  MUC16  TCF19  MUC17  THAP3  MUC2  TMUB2  MYOM2  TNRC18  PCDHB10  TNRC6C  SYNE1  USP48  TECTA  USP9Y  TMEM131  WDR81  VPS13A  ZC3H7B  Count  21  21 3 gene sharing pattern.",
            "section": "Other cancer type None",
            "ref_spans": [
                {
                    "start": 30,
                    "end": 357,
                    "type": "table",
                    "ref_id": "tab_0",
                    "text": "ANKRD18A  C6orf10  FOXD4L6  CDH23  CDSN  HELZ2  CYFIP1  DMBT1  DNAH17  GRIK1  DNAH8  KIF16B  FAM195A  KIFC2  GPR98  MUC5B  ITGAX  MUC6  KIAA1199  MYH10  LAMC3  OR6V1  MLL3  PITRM1  MUC16  TCF19  MUC17  THAP3  MUC2  TMUB2  MYOM2  TNRC18  PCDHB10  TNRC6C  SYNE1  USP48  TECTA  USP9Y  TMEM131  WDR81  VPS13A  ZC3H7B  Count  21  21"
                }
            ],
            "entity_spans": [
                {
                    "type": "software",
                    "start": 344,
                    "end": 349,
                    "rawForm": "Count",
                    "resp": "whitelist",
                    "id": "fd1a8548c9-software-simple-w7"
                }
            ]
        },
        {
            "text": "In this study, we proposed a workflow of matched normal AML exome sequencing analysis and the framework for defining sample subgroups. ",
            "section": "Discussion"
        },
        {
            "text": "We observed every sample having a nonsynonymous mutation associated with hematological and lymphoid malignancy genes, but the candidate oncogenes showed diverse characters.",
            "section": "Discussion"
        },
        {
            "text": "We selected 45 genes that had 3 or more nonsynonymous mutations and performed hierarchical clustering analysis of the samples by these genes. ",
            "section": "Discussion"
        },
        {
            "text": "In classic hierarchical clustering analysis by Ward's method, we could not identify the genetic relationship of those clusters. ",
            "section": "Discussion"
        },
        {
            "text": "On the other hand, the result of concept lattice analysis gave us insight into the mutational pattern of each sample.",
            "section": "Discussion"
        },
        {
            "text": "In subgroup 1, samples 3, 4, and 7 shared SYNE1 gene mutations. ",
            "section": "Discussion"
        },
        {
            "text": "SYNE1 gene encodes a spectrin repeat-containing protein expressed in skeletal and smooth muscle and peripheral blood lymphocytes that localizes to the nuclear membrane [21]. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 168,
                    "end": 172,
                    "type": "bibr",
                    "ref_id": "b20",
                    "text": "[21]"
                }
            ]
        },
        {
            "text": "This gene is not a well-known leukemic gene but is observed in some hematological malignancies and other cancer types [22]. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 118,
                    "end": 122,
                    "type": "bibr",
                    "ref_id": "b21",
                    "text": "[22]"
                }
            ]
        },
        {
            "text": "In glioblastoma, SYNE1 mutation is significantly correlated with the overexpression of several known glioblastoma survival genes [23]. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 129,
                    "end": 133,
                    "type": "bibr",
                    "ref_id": "b22",
                    "text": "[23]"
                }
            ]
        },
        {
            "text": "In the case of sample 3, the ITGAX gene, encoding ankyrin repeat domain 18A, was mutated. ",
            "section": "Discussion"
        },
        {
            "text": "This gene is well known by the association with leukemia [24] and lung cancer [25]. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 57,
                    "end": 61,
                    "type": "bibr",
                    "ref_id": "b23",
                    "text": "[24]"
                },
                {
                    "start": 78,
                    "end": 82,
                    "type": "bibr",
                    "ref_id": "b24",
                    "text": "[25]"
                }
            ]
        },
        {
            "text": "For sample 4, the possible oncogene is LAMC3. ",
            "section": "Discussion"
        },
        {
            "text": "LAMC3 gene encodes laminins, which are the major non-collagenous constituent of basement membrane. ",
            "section": "Discussion"
        },
        {
            "text": "LAMC3 mutations are associated with several cancers, including colon cancer, lung cancer, and melanoma, and candidate tumor suppressor genes in bladder transitional cell carcinoma [26]. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 180,
                    "end": 184,
                    "type": "bibr",
                    "ref_id": "b25",
                    "text": "[26]"
                }
            ]
        },
        {
            "text": "LAMC3 is involved in the phosphatidylinositol 3-kinase-Akt signaling pathway, since it has a role in cell adhesion. ",
            "section": "Discussion"
        },
        {
            "text": "The ANKRD18A gene is the oncogene candidate for sample 7 and is a novel epigenetic regulation gene in lung cancer [25]. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 114,
                    "end": 118,
                    "type": "bibr",
                    "ref_id": "b24",
                    "text": "[25]"
                }
            ]
        },
        {
            "text": "Therefore, it is possible that the pair relationship of those genes (ITGAX-SYNE1, LAMC3-SYNE1, and ANKRD18A-SYNE1) could contribute together to evolve the leukemic cell transformation.",
            "section": "Discussion"
        },
        {
            "text": "The major limitation of our study is that we could not validate the mutation results by Sanger method or deep Genomics & Informatics Vol. 11, No. 1, 2013 sequencing. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 110,
                    "end": 153,
                    "type": "bibr",
                    "text": "Genomics & Informatics Vol. 11, No. 1, 2013"
                }
            ]
        },
        {
            "text": "We selected highly mutated genes having 3 mutations or more, but this definition is arbitrary, so we might have lost candidate oncogenes in some patients.",
            "section": "Discussion"
        },
        {
            "text": "In this study, we suggest the concept of clustering samples that have diverse mutated genes. ",
            "section": "Discussion"
        },
        {
            "text": "AML is very heterogeneous genetic disease. ",
            "section": "Discussion"
        },
        {
            "text": "Despite the small number of samples we have studied, the genetic variation patterns were not common for all samples. ",
            "section": "Discussion"
        },
        {
            "text": "It could have been better to evaluate more sample data for analysis by clustering analysis.",
            "section": "Discussion"
        },
        {
            "text": "This work was supported by the basic science research program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2012-0000994). ",
            "section": "Acknowledgments",
            "entity_spans": [
                {
                    "type": "software",
                    "start": 54,
                    "end": 61,
                    "rawForm": "program",
                    "resp": "whitelist",
                    "id": "fd1a8548c9-software-simple-w8"
                },
                {
                    "type": "software",
                    "start": 92,
                    "end": 102,
                    "rawForm": "Foundation",
                    "resp": "whitelist",
                    "id": "fd1a8548c9-software-simple-w9"
                }
            ]
        },
        {
            "text": "This material is based upon work supported by the Korea Genome Organization.",
            "section": "Acknowledgments"
        }
    ]
}